Skip to main content

ThinkTrends Agentic AI Goes Live With the U.S. Food and Drug Administration’s Nationwide Adverse Event Monitoring System

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ThinkTrends agentic Document AI platform has been deployed at the U.S. Food and Drug Administration (FDA) as part of its new nationwide Adverse Event Monitoring System (AEMS), a major modernization initiative to improve how safety signals across drugs, vaccines, cosmetics, foods, medical devices, and other regulated products are monitored. The new platform replaces multiple fragmented reporting systems with a single real-time monitoring environment designed to process millions of adverse event reports each year across the agency’s product centers.

ThinkTrends agentic Document AI platform plays a critical role in the new system by handling unstructured safety data intake across centers. From emailed forms to scanned PDFs and handwritten reports, the system automates the extraction, normalization, and regulatory conversion of safety data. Using advanced AI, reports are classified, coded, and converted into structured outputs that accelerate the agency’s ability to analyze and act on emerging safety concerns.

The agency estimates approximately six to seven million adverse event reports are processed annually across multiple databases. ThinkTrends agentic Document AI platform for pharmacovigilance intake played a key role in this modernization effort by automating the ingestion, classification, and normalization of large volumes of adverse event data across the agency’s multiple product centers. By consolidating these systems into a unified AI-enabled platform, the new AEM is expected to improve speed, accuracy, and accessibility.

Modernizing adverse event monitoring at a national scale required consolidating multiple legacy systems, handling millions of safety reports, and delivering a reliable platform on an accelerated timeline,” said Jyotiska Biswas, CEO of ThinkTrends. “We are proud to support the FDA in deploying a system that strengthens real-time safety surveillance for regulators, researchers, and the public.

About ThinkTrends

ThinkTrends is a leader in regulated enterprise and federal AI systems, specializing in no-code agentic AI platforms, secure large-language-model deployments, document automation, and AI governance solutions. With a mission to bring trustworthy, high-performance AI to regulated sectors, ThinkTrends supports clients across life science, finance, and federal agencies. Learn more at ThinkTrends.co.

“Modernizing adverse event monitoring at a national scale required consolidating multiple legacy systems, handling millions of safety reports, and delivering a reliable platform on an accelerated timeline,” said Jyotiska Biswas, CEO of ThinkTrends.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  261.12
+0.00 (0.00%)
AAPL  267.61
+0.00 (0.00%)
AMD  334.63
+0.00 (0.00%)
BAC  52.63
+0.00 (0.00%)
GOOG  348.52
+0.00 (0.00%)
META  678.62
+0.00 (0.00%)
MSFT  424.82
+0.00 (0.00%)
NVDA  216.61
+0.00 (0.00%)
ORCL  172.96
+0.00 (0.00%)
TSLA  378.67
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.